Halozyme Therapeutics
HALO
#2020
Rank
S$10.39 B
Marketcap
$84.18
Share price
1.86%
Change (1 day)
54.08%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): S$0.74 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$1.01 Billion. , an increase over its 2023 earnings that were of S$0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 S$0.74 B59.94%
2023 S$0.46 B39.94%
2022 S$0.33 B0.16%
2021 S$0.33 B92.2%
2020 S$0.17 B-278.96%
2019 -S$96.51 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$82.29 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$43.06 Million-52.86%
2014 -S$91.34 Million-18.09%
2013 -S$0.12 Billion55.88%
2012 -S$71.54 Million169.94%
2011 -S$26.51 Million-63.44%
2010 -S$72.48 Million-7.19%
2009 -S$78.09 Million15.91%
2008 -S$67.37 Million83.89%
2007 -S$36.64 Million78.1%
2006 -S$20.58 Million16%
2005 -S$17.74 Million45.24%
2004 -S$12.21 Million682.42%
2003 -S$1.57 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$40.76 M-94.52%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.93 B 2,176.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.8 Billion-206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
S$14.84 B 1,894.68%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.60 B 1,325.52%๐Ÿ‡ซ๐Ÿ‡ท France
S$23.29 B 3,030.68%๐Ÿ‡บ๐Ÿ‡ธ USA